Fehlings Michael G, Arvin Babak
J Neurosurg Spine. 2009 Aug;11(2):97-100. doi: 10.3171/2009.5.SPINE09210.
In this special edition of Journal of Neurosurgery: Spine, a series of systematic reviews sponsored by the Section on Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons/Congress of Neurological Surgeons is presented. This collection of comprehensive reviews summarizes the medical evidence related to the surgical management of cervical degenerative disc disease. Several of the key conclusions are discussed in this introduction to the issue: There is Class II evidence to suggest that the clinical condition remains stable when observed over a 3-year period in patients with mild-to-moderate cervical spondylotic myelopathy (CSM) and age younger than 75 years. There is consistent Class III evidence that the duration of symptoms, and possibly advancing age, negatively affect outcome in patients with CSM. There is Class II evidence that somatosensory evoked potentials have prognostic value in patients with CSM. There is Class I evidence to show that electromyographic abnormalities (as well as the presence of radiculopathy) are predictive of the development of myelopathy in minimally symptomatic patients with cervical stenosis and spinal cord compression. The presence of a low signal on T1-weighted images, high signal on T2-weighted images, and the presence of cord atrophy on preoperative MR images are indicators of a poor outcome in CSM. There is Class III evidence to show that anterior or posterior surgical approaches that effectively decompress the cervical canal promote short-term improvements in outcome. However, there appears to be a risk of late kyphosis in patients who undergo laminectomy or anterior cervical discectomy alone compared with patients in whom decompression is combined with fusion. The use of BMP-2 is discouraged for anterior cervical spine surgery based on evidence suggesting that the risks outweigh any potential benefits. Finally, in patients with symptomatic cervical radiculopathy, arthroplasty achieves outcomes that are equivalent to anterior cervical decompression and fusion, although evidence for superiority is lacking. Further prospective longitudinal data are required to better define the role and timing of surgical intervention in CSM and to determine the appropriate use of cervical arthroplasty in the management of symptomatic cervical degenerative disc disease.
在《神经外科杂志:脊柱》的这一特刊中,展示了由美国神经外科医师协会/神经外科医师大会脊柱与周围神经疾病分会赞助的一系列系统评价。这组全面的综述总结了与颈椎退行性椎间盘疾病手术治疗相关的医学证据。在本期引言中讨论了几个关键结论:有II类证据表明,年龄小于75岁的轻度至中度脊髓型颈椎病(CSM)患者在3年观察期内临床状况保持稳定。有一致的III类证据表明,症状持续时间以及可能的年龄增长对CSM患者的预后有负面影响。有II类证据表明体感诱发电位对CSM患者有预后价值。有I类证据表明,肌电图异常(以及神经根病的存在)可预测轻度症状性颈椎管狭窄和脊髓受压患者发生脊髓病。术前磁共振图像上T1加权像低信号、T2加权像高信号以及脊髓萎缩的存在是CSM预后不良的指标。有III类证据表明,有效减压颈椎管的前路或后路手术方法可促进短期内预后改善。然而,与减压联合融合的患者相比,单纯接受椎板切除术或前路颈椎间盘切除术的患者似乎有后期后凸畸形的风险。基于风险大于任何潜在益处的证据,不建议在颈椎前路手术中使用骨形态发生蛋白-2(BMP-2)。最后,在有症状的颈椎神经根病患者中,关节成形术的疗效与颈椎前路减压融合术相当,尽管缺乏优越性的证据。需要进一步的前瞻性纵向数据来更好地界定CSM手术干预的作用和时机,并确定颈椎关节成形术在有症状颈椎退行性椎间盘疾病管理中的适当应用。